Inventor profile of:

Flavius Martin

City:

Hayward, California

Country:

United States

Published Applications:

16

Last publication date:

2014-12-25

Top Assignees for applications by Flavius Martin

The entities that hold a legal rights for patent applications filed by inventor Martin Flavius:

Recent patent applications by Martin Flavius

Flavius Martin from Hayward, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-12-25
US20140377257A1
Human necessities

COMBINATION THERAPY FOR B CELL DISORDERS

#2 | 2014-11-20
US20140341887A1
Chemistry; metallurgy

Methods for treating, diagnosing, and monitoring rheumatoid arthritis

#3 | 2014-07-31
US20140213470A1
Chemistry; metallurgy

METHODS FOR USE WITH BAFF ANTAGONISTS

#4 | 2011-03-03
US20110052488A1
Chemistry; metallurgy

Methods for treating, diagnosing, and monitoring rheumatoid arthritis

#5 | 2010-12-30
US20100330066A1
Chemistry; metallurgy

Methods for use with BAFF antagonists

#6 | 2010-11-04
US20100280227A1
Chemistry; metallurgy

POLYPEPTIDES THAT BIND BR3 AND USES THEREOF

#7 | 2010-10-28
US20100272738A1
Chemistry; metallurgy

ANTI-OX40L ANTIBODIES AND METHODS USING SAME

#8 | 2010-06-10
US20100143352A1
Human necessities

COMBINATION THERAPY FOR B CELL DISORDERS

#9 | 2009-02-26
US20090053230A1
Chemistry; metallurgy

Anti-OX40L antibodies and methods using same

#10 | 2008-07-31
US20080181888A1
Chemistry; metallurgy

Polypeptides That Bind Br3 and Uses Thereof

#11 | 2008-03-27
US20080075719A1
Chemistry; metallurgy

Method for Augmenting B Cell Depletion

#12 | 2007-09-13
US20070212733A1
Physics

Methods and compositions related to B cell assays

#13 | 2006-09-28
US20060218655A1
Chemistry; metallurgy

Transgenic mice expressing human CD20 and/or CD16

#14 | 2005-12-15
US20050276803A1
Chemistry; metallurgy

Method for augmenting B cell depletion

#15 | 2005-07-28
US20050163775A1
Chemistry; metallurgy

Combination therapy for B cell disorders

#16 | 2005-05-05
US20050095243A1
Human necessities

Combination therapy for B cell disorders

InventorID:

855019 ⎘